File Manager / wp-content Search Upload New Item Settings File "db5.php" Full path: /home1/epichome/public_html/wp-content/db5.php File size: 60.67 B (60.67 KB bytes) MIME-type: text/x-php Charset: utf-8 Download Open Edit Advanced Editor Back
/home/pharmacy/mail/pharmacycouncil.rw/innocent.hahirwa/dovecot.index.cache
���^���^I�������~�^4�^sDcsDcsDc�������������������������������������������������flagsdate.sentdate.receiveddate.savesize.virtualsize.physicalimap.bodyimap.bodystructureimap.envelopepop3.uidlpop3.orderguidmime.partsbinary.partsbody.snippethdr.Fromhdr.Message-IDhdr.Subjecthdr.Date�IFrom: "cPanel on pharmacycouncil.rw" <cpanel@pharmacycouncil.rw>
VMessage-Id: <1589877384.ETDXnSqpfXviaeFZ@uscentral426.accountservergroup.com>
�Subject: =?UTF-8?B?W3BoYXJtYWN5Y291bmNpbC5yd10gRW1haWwgY29uZmlndXJhdGlv?= =?UTF-8?B?biBzZXR0aW5ncyBmb3Ig4oCcaW5ub2NlbnQuaGFoaXJ3YUBwaGFybWFjeWNv?= =?UTF-8?B?dW5jaWwucnfigJ0u?=
 �;+From: Innocent Hahirwa <innocenthahirwa@gmail.com>
Y-Message-ID: <CAP4jP1dV6ex7yuWDfv7me5OJBy-GZEgxHcy0-2CsJaU15sVFrQ@mail.gmail.com>
.Subject: hi
 ( E1From: National Pharmacy Council Rwanda <rwandanpc@gmail.com>
Y3Message-ID: <CAF5RQ=Jh60K2-zSWc=ySgPU_nQURD24i+_UtJG+Pq-roZA0arw@mail.gmail.com>
[4Subject: Re: Support to the ongoing National efforts against the COVID-19 Pandemic
( KFrom: "Patrick Rugambya/NPC" <rugambya.patrick@pharmacycouncil.rw>
IMessage-ID: <006c01d62e9d$8a6bebc0$9f43c340$@pharmacycouncil.rw>
gSubject: Progress report / Fundraising in support to the National efforts against the Covid-19
, ;3From: Innocent Hahirwa <innocenthahirwa@gmail.com>
Y5Message-ID: <CAP4jP1dSM1GvEPfYBiQwGG5saWBNwjQ5TkuFUU585s=yEARj0Q@mail.gmail.com>
l6Subject: Re: Progress report / Fundraising in support to the National efforts
 against the Covid-19
, KFrom: "Patrick Rugambya/NPC" <rugambya.patrick@pharmacycouncil.rw>
IMessage-ID: <004701d63047$5e63fa30$1b2bee90$@pharmacycouncil.rw>
kSubject: RE: Progress report / Fundraising in support to the National efforts against the Covid-19
, KFrom: "Patrick Rugambya/NPC" <rugambya.patrick@pharmacycouncil.rw>
IMessage-ID: <002401d632b0$21443780$63cca680$@pharmacycouncil.rw>
kSubject: RE: Progress report / Fundraising in support to the National efforts against the Covid-19
, ;2From: Innocent Hahirwa <innocenthahirwa@gmail.com>
Y4Message-ID: <CAP4jP1fQPDNBb4Rxk8PjhbavaNR83sFd=8sBm95TfTQHwqq03Q@mail.gmail.com>
l5Subject: Re: Progress report / Fundraising in support to the National efforts
 against the Covid-19
  /3From: Darius Uzab <uzdallas@gmail.com>
Y5Message-ID: <CAKCbWjA6P9fy5s6Wp7OW-zpGyJURpGXGpkPVc2_qkFLEjJT8vQ@mail.gmail.com>
l6Subject: Re: Progress report / Fundraising in support to the National efforts
 against the Covid-19
� KFrom: "Patrick Rugambya/NPC" <rugambya.patrick@pharmacycouncil.rw>
IMessage-ID: <000c01d63408$2fd15900$8f740b00$@pharmacycouncil.rw>
/Subject: May 2020 registration session
� ;0From: Innocent Hahirwa <innocenthahirwa@gmail.com>
Y2Message-ID: <CAP4jP1c1t4e6E0ZUf3vhzEdEVU6qwk5eghhUB_htyturf1qcwQ@mail.gmail.com>
33Subject: Re: May 2020 registration session
, ;4From: Innocent Hahirwa <innocenthahirwa@gmail.com>
Y6Message-ID: <CAP4jP1dZ=KhX5qfyTthgHx9NUcYKkhK4fiU4JgctGLUGX5U_3A@mail.gmail.com>
l7Subject: Re: Progress report / Fundraising in support to the National efforts
 against the Covid-19
  /4From: Darius Uzab <uzdallas@gmail.com>
Y6Message-ID: <CAKCbWjA=a7UwmxhEn1v-ejNgxWiy67qhFUJCigxE1WtRYDHxTw@mail.gmail.com>
l7Subject: Re: Progress report / Fundraising in support to the National efforts
 against the Covid-19
�6From: <bimenyimana.fidele@pharmacycouncil.rw>
IMessage-ID: <000a01d638ce$a9758cc0$fc60a640$@pharmacycouncil.rw>
Subject: NPC WEBINAR
 K
From: "Patrick Rugambya/NPC" <rugambya.patrick@pharmacycouncil.rw>
IMessage-ID: <003601d63993$62579110$2706b330$@pharmacycouncil.rw>
TSubject: NPC web-based application/ Request of extension of contract period
  ;/From: Innocent Hahirwa <innocenthahirwa@gmail.com>
Y1Message-ID: <CAP4jP1fv4iMhp9SPoDzQvsfH-PThJJJyanna9ymbKpH0UhBUng@mail.gmail.com>
X2Subject: Re: NPC web-based application/ Request of extension of contract period
 //From: Darius Uzab <uzdallas@gmail.com>
Y1Message-ID: <CAKCbWjDh6=x4+ABpWZJQ98-QCdyi-jp_tyeLvQVXTyBzHDCuwA@mail.gmail.com>
X2Subject: Re: NPC web-based application/ Request of extension of contract period
 ;0From: Innocent Hahirwa <innocenthahirwa@gmail.com>
Y2Message-ID: <CAP4jP1fpwQ3A2Bx3j0Kbj7xGx+ZRoHCHQTne7mTQHBmH9qkrAA@mail.gmail.com>
X3Subject: Re: NPC web-based application/ Request of extension of contract period
;+From: Innocent Hahirwa <innocenthahirwa@gmail.com>
Y-Message-ID: <CAP4jP1ehUpc_tp2uE3BMfth0puW1kJaEqX-kAA6BuYaTupa=ZA@mail.gmail.com>
A.Subject: Request for appointment to receive our donation
 �/"From: Daniel Ngamije <dngamije@gov.rw>
>/Message-ID: <c7a740b1126143bfb15beeeffd939dcd@gov.rw>
E+Subject: Re: Request for appointment to receive our donation
 ;0From: Innocent Hahirwa <innocenthahirwa@gmail.com>
Y2Message-ID: <CAP4jP1cPRF1RnHBzoUGOfj0M8Xz2yNS0p8oSzwUKvghXA0aY8g@mail.gmail.com>
E3Subject: Re: Request for appointment to receive our donation
 �K
From: "Patrick Rugambya/NPC" <rugambya.patrick@pharmacycouncil.rw>
IMessage-ID: <001501d642f3$77d4a8c0$677dfa40$@pharmacycouncil.rw>
2Subject: Invitation to the Board meeting 
 �K
From: "Patrick Rugambya/NPC" <rugambya.patrick@pharmacycouncil.rw>
IMessage-ID: <003501d64306$38719180$a954b480$@pharmacycouncil.rw>
6Subject: RE: Invitation to the Board meeting 
 � ;.From: Innocent Hahirwa <innocenthahirwa@gmail.com>
Y0Message-ID: <CAP4jP1fmYYU_xvL6M23N8iXqw=0zebXSUO+pw2h4VN=tcqEa0g@mail.gmail.com>
51Subject: Re: Invitation to the Board meeting
�J
From: "Blaise Pascal Ishimwe" <blaise.ishimwe@pharmacycouncil.rw>
IMessage-ID: <002001d643b4$7f42d930$7dc88b90$@pharmacycouncil.rw>
*Subject: Renewal license- Remind 
 K
From: "Patrick Rugambya/NPC" <rugambya.patrick@pharmacycouncil.rw>
IMessage-ID: <001901d6463d$5c87a070$1596e150$@pharmacycouncil.rw>
CSubject: INFORMATION ON REGISTERED PHARMACY PROFESSIONALS 
 �K
From: "Patrick Rugambya/NPC" <rugambya.patrick@pharmacycouncil.rw>
IMessage-ID: <002801d6463e$33338760$999a9620$@pharmacycouncil.rw>
,Subject: REVISED INVITATION LETTER 
  ?From: Parfait Uwaliraye <parfait.uwaliraye@moh.gov.rw>
e'Message-ID: <CH2PR14MB40213264DBECED085A456A1AFD980@CH2PR14MB4021.namprd14.prod.outlook.com>
G#Subject: Re: INFORMATION ON REGISTERED PHARMACY PROFESSIONALS 
� ?From: Parfait Uwaliraye <parfait.uwaliraye@moh.gov.rw>
B'Message-ID: <74ed798cdf3f40e78a540ed225d26777@moh.gov.rw>
G#Subject: RE: INFORMATION ON REGISTERED PHARMACY PROFESSIONALS 
 E+From: National Pharmacy Council Rwanda <rwandanpc@gmail.com>
Y-Message-ID: <CAF5RQ=+ykfixY6n7FXkwoibOYcG9ga=7-EQeB7VMfz1HX=buWA@mail.gmail.com>
=.Subject: Rwanda Pharmacy council_New contact persons
 3FFrom: Rachel van Kesteren <Rachel@fip.org>
eRMessage-ID:
 <AM6P193MB03752936BB7C555CF0AC90B7C06A0@AM6P193MB0375.EURP193.PROD.OUTLOOK.COM>
ANSubject: RE: Rwanda Pharmacy council_New contact persons
 E0From: National Pharmacy Council Rwanda <rwandanpc@gmail.com>
Y2Message-ID: <CAF5RQ=K4YL2H8kKAKF3k_jX_qrWkRm88fL=1mxgwcqXKB7vnKg@mail.gmail.com>
A3Subject: Re: Rwanda Pharmacy council_New contact persons
L`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200706081415.bd646ff87f.0787a233@mail86.atl261.mcdlv.net>
KSubject: =?utf-8?Q?FIP=20&=20COVID=2D19=3A=20Latest=20activities?=
 �K
From: "Patrick Rugambya/NPC" <rugambya.patrick@pharmacycouncil.rw>
IMessage-ID: <001e01d6544f$6b17f4d0$4147de70$@pharmacycouncil.rw>
&Subject: NPC Registrants data
 � EFrom: jeanbosco ndayambaje <jeanbosco.ndayambaje@moh.gov.rw>
B#Message-ID: <1dd23518d4c14dc380b0e19e30b4add4@moh.gov.rw>
*Subject: Re: NPC Registrants data
(3GFrom: Rachel van Kesteren <Rachel@fip.org>
eOMessage-ID:
 <AM6P193MB0375CB5DF732F3F5855A4A94C0640@AM6P193MB0375.EURP193.PROD.OUTLOOK.COM>
dISubject: Subject: Virtual FIP Council meeting invitation - please rsvp before
 25 July 2020
 XTFrom: =?utf-8?Q?International=20Pharmaceutical=20Federation?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200713081411.a3a434dfd2.c21aa2cf@mail74.atl111.rsgsv.net>
bSubject: =?utf-8?Q?FIP=20Development=20Goals=20set=20to=20transform=20global=20pharmacy?=
 � KFrom: "Patrick Rugambya/NPC" <rugambya.patrick@pharmacycouncil.rw>
IMessage-ID: <000001d65934$74b79c90$5e26d5b0$@pharmacycouncil.rw>
'Subject: NPC Quarterly report 
� ;0From: Innocent Hahirwa <innocenthahirwa@gmail.com>
Y2Message-ID: <CAP4jP1d1AgAJd3-HXZcLqycuu2x-qLOUSc4dg0VxBoAks1-B=A@mail.gmail.com>
*3Subject: Re: NPC Quarterly report
,3FFrom: Rachel van Kesteren <Rachel@fip.org>
eOMessage-ID:
 <AM6P193MB0375FE7F779D251E1E557341C07F0@AM6P193MB0375.EURP193.PROD.OUTLOOK.COM>
gISubject: Member Engagement event in the African region 23 July 2020 - Survey
 and meeting link
 @`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200720100746.455116200e.035ece81@mail86.atl261.mcdlv.net>
@Subject: =?utf-8?Q?FIP=20COVID=2D19=20Bulletin=20July?=
 �?From: Parfait Uwaliraye <parfait.uwaliraye@moh.gov.rw>
BCMessage-ID: <f93ced3fa4ad4eee95736f76cc09b860@moh.gov.rw>
C?Subject: Introducing the new PS MOH- Mr Zachee Iyakaremye 
 A/From: Gasherebuka Jean Damascene <gasherebuka@gmail.com>
Y1Message-ID: <CAFVeBOUDChthDAuEG_zfHar6Dsnx_5=OzTZz87ehPhqkNkUNAg@mail.gmail.com>
F2Subject: Re: Introducing the new PS MOH- Mr Zachee Iyakaremye
 >/From: Jean Claude Byiringiro <jcbyiringiro@gmail.com>
Y1Message-ID: <CAHbgRAyjGdMQPL2vdb2FZNGpFtqc4MJyv2WDnH5qb7raDUFV3Q@mail.gmail.com>
F2Subject: Re: Introducing the new PS MOH- Mr Zachee Iyakaremye
 5/From: INNOCENT KAGABO <kagabo2014@gmail.com>
Y1Message-ID: <CAP7a6KNwSOQESjgeOrz_XyhyfM6pEeBVui=EiEMC5iu1=c-NyA@mail.gmail.com>
F2Subject: Re: Introducing the new PS MOH- Mr Zachee Iyakaremye
 �1GFrom: Ananias Sentozi <asentozi@wvi.org>
XHMessage-ID: <OFBEDAF56C.968B7791-ON422585AC.0067F4BC-422585AC.006DEBAC@wvi.org>
FDSubject: Re: Introducing the new PS MOH- Mr Zachee Iyakaremye
 A(From: Perpetue Kamuyumbu <pkamuyumbu@waterforpeople.org>
fSMessage-ID:
 <BY5PR18MB3089D1E1804D78722D03E1CBB7790@BY5PR18MB3089.namprd18.prod.outlook.com>
GOSubject: RE: Introducing the new PS MOH- Mr Zachee Iyakaremye 
 6/From: sage semafara <ssage.rrpplus@gmail.com>
Y1Message-ID: <CADAMq0K6h_HrYSc79rCmKXomhXFsdB+=4fB76odRmdjEgJc31g@mail.gmail.com>
F2Subject: Re: Introducing the new PS MOH- Mr Zachee Iyakaremye
 ;/From: Innocent Hahirwa <innocenthahirwa@gmail.com>
Y1Message-ID: <CAP4jP1fA709LRiHknpxL1emaszq-6PFuKS7A_w_1xHNnU48V1Q@mail.gmail.com>
F2Subject: Re: Introducing the new PS MOH- Mr Zachee Iyakaremye
 @,EFrom: Nilhan Uzman <Nilhan@fip.org>
eQMessage-ID:
 <AM6P193MB026326EA38A8E7AAB168F728DD790@AM6P193MB0263.EURP193.PROD.OUTLOOK.COM>
�ISubject:
 =?utf-8?B?RklQIE1PIMOJdsOpbmVtZW50IGQnZW5nYWdlbWVudCBkZXMgbWVtYnJlcyBS?=
 =?utf-8?B?w6lnaW9uIGFmcmljYWluZQ==?=
 $*DFrom: Paula Cohen <Paula@fip.org>
eLMessage-ID:
 <AM6P193MB0326266B990F36167FC8534EB8770@AM6P193MB0326.EURP193.PROD.OUTLOOK.COM>
gFSubject: FIP Regulators Forum - Election for new Chair - please send
 nominations by 25 August
 LTFrom: =?utf-8?Q?International=20Pharmaceutical=20Federation?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200727092444.601ee48c19.3307c7eb@mail74.atl111.rsgsv.net>
USubject: =?utf-8?Q?FIP=E2=80=99s=20programme=20of=20work=20on=20prevention?=
 3DFrom: Rachel van Kesteren <Rachel@fip.org>
eMMessage-ID:
 <AM6P193MB037515C9D02C8AC1586F3660C0730@AM6P193MB0375.EURP193.PROD.OUTLOOK.COM>
KISubject: FIP Member Engagement event 23 July 2020 - African region
 x`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200730140906.691c25d17d.7a0e29cd@mail198.suw16.rsgsv.net>
vSubject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28July=29?=
 3EFrom: Rachel van Kesteren <Rachel@fip.org>
eKMessage-ID:
 <AM6P193MB03757895739139270A28EBBCC04E0@AM6P193MB0375.EURP193.PROD.OUTLOOK.COM>
MGSubject: Agenda for virtual Council meeting 12 and 13 September 2020
 ``From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200803085922.03cb831f06.9671a967@mail236.suw14.mcdlv.net>
`Subject: =?utf-8?Q?COVID=2D19=3A=20Presenting=20evidence=20and=20gathering=20evidence?=
 t`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200806140234.a3d8803e22.440d5543@mail198.suw16.rsgsv.net>
tSubject: =?utf-8?Q?FIP=20Pharmaceutical=20Sciences=20World=20Congress=20=28PSWC=202020=29=3A=20Virtual=21?=
 �E+From: National Pharmacy Council Rwanda <rwandanpc@gmail.com>
Y-Message-ID: <CAF5RQ=L5Jpki7=XeBSz4X6kcL_wVfrTsYZkCv7zNiCeW3xuwUg@mail.gmail.com>
.Subject: Public notice
 L`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200810092941.d446e9e3c7.63935b0f@mail102.sea21.rsgsv.net>
ISubject: =?utf-8?Q?FIP=20leads=20focus=20on=20patient=20safety?=
 D`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200817080551.356528338a.ab2b365a@mail85.atl261.mcdlv.net>
BSubject: =?utf-8?Q?FIP=20COVID=2D19=20Bulletin=20August?=
 *DFrom: Paula Cohen <Paula@fip.org>
eLMessage-ID:
 <AM6P193MB0326D1C0D7949EFA49005842B85F0@AM6P193MB0326.EURP193.PROD.OUTLOOK.COM>
YFSubject: Call for nominations Host Madsen 2021 - MOs - deadline 1 December
 2020
 `TFrom: =?utf-8?Q?International=20Pharmaceutical=20Federation?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200817125910.074e7c0766.b0ffa198@mail160.atl271.mcdlv.net>
jSubject: =?utf-8?Q?Join=20FIP=E2=80=99s=20Digital=20Health=20in=20Pharmacy=20Education=20Survey?=
  E*From: National Pharmacy Council Rwanda <rwandanpc@gmail.com>
Y,Message-ID: <CAF5RQ=LxTT1qumxgpRUYnujJX2Sa1cQepyZmRDNrDnk0wC_pqg@mail.gmail.com>
?-Subject: Pre-registration Examination Guidelines Draft
x`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
rMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200824092916.9971c2f9e5.1ff2817f@mail37.us4.mcsv.net>
zSubject: =?utf-8?Q?Global=20Pharmaceutical=20Observatory=20will=20bring=20many=20benefits=20for=20our=20members?=
 Q'From: Gasingirwa Marie-Christine <mariechristine_gasingirwa@yahoo.co.uk>
F.Message-ID: <1109345644.7888031.1598274555171@mail.yahoo.com>
</Subject: Submission of the inputs on the Guidelines
 tTFrom: =?utf-8?Q?International=20Pharmaceutical=20Federation?= <fip@fip.org>
tMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200824144736.51804a0d89.c9f9f91f@mail57.suw15.mcsv.net>
�Subject: =?utf-8?Q?Register=20FIP=20&=20AACP=20Academic=20Leadership=20Course=20to=20Navigate=20COVID=2D19=20Challenges?=
 K
From: "Patrick Rugambya/NPC" <rugambya.patrick@pharmacycouncil.rw>
IMessage-ID: <005701d67ae6$c7e552d0$57aff870$@pharmacycouncil.rw>
@Subject: RE: Submission of the inputs on the Guidelines
 3DFrom: Rachel van Kesteren <Rachel@fip.org>
eJMessage-ID:
 <AM9P193MB08723D2EBEBD6CB1CAB7AB22C0540@AM9P193MB0872.EURP193.PROD.OUTLOOK.COM>
QFSubject: FW: Agenda for virtual Council meeting 12 and 13 September 2020
 x`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200827122223.1383e990a8.f67d05fb@mail25.atl261.mcdlv.net>
xSubject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28August=29?=
 *EFrom: Paula Cohen <Paula@fip.org>
eMMessage-ID:
 <AM6P193MB03268824B9126558F0FFFAD5B8520@AM6P193MB0326.EURP193.PROD.OUTLOOK.COM>
[GSubject: FW: Invitation to Regulators Forum meeting - 9 September - kind
 reminder
 D`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200831091431.c78960521e.6c7fb3d1@mail32.sea91.rsgsv.net>
BSubject: =?utf-8?Q?COVID=2D19=3A=20News=20and=20updates?=
 � KFrom: "Patrick Rugambya/NPC" <rugambya.patrick@pharmacycouncil.rw>
IMessage-ID: <000001d6802f$786547d0$692fd770$@pharmacycouncil.rw>
4Subject: ISHIMWE Blaise_Resignation letter 
� /1From: Darius Uzab <uzdallas@gmail.com>
Y3Message-ID: <CAKCbWjAe_2zWpoBWVkLta-T+tsq0bVAFxhX1qxU3+jg4rg-NPg@mail.gmail.com>
74Subject: Re: ISHIMWE Blaise_Resignation letter
� ;1From: Innocent Hahirwa <innocenthahirwa@gmail.com>
Y3Message-ID: <CAP4jP1cab9DCV13W6nUehZ6N2Q7ZbXwiAypqDB2z4phxfxo6CQ@mail.gmail.com>
74Subject: Re: ISHIMWE Blaise_Resignation letter
XTFrom: =?utf-8?Q?International=20Pharmaceutical=20Federation?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200902074726.7ace1475da.aec3900a@mail59.suw13.rsgsv.net>
cSubject: =?utf-8?Q?Join=20=22Driving=20AMR=20action=20in=20a=20new=20decade=22=20session?=
 � KFrom: "Patrick Rugambya/NPC" <rugambya.patrick@pharmacycouncil.rw>
IMessage-ID: <007701d681ce$9ffccfc0$dff66f40$@pharmacycouncil.rw>
.Subject: PRE-REGISTRATION EXAMINATION
� /1From: Darius Uzab <uzdallas@gmail.com>
Y3Message-ID: <CAKCbWjAnN4RiKcbP=jqYcm5-u4xN3hTsjeNDUB7JVLn1HJbsww@mail.gmail.com>
24Subject: Re: PRE-REGISTRATION EXAMINATION
� ;1From: Innocent Hahirwa <innocenthahirwa@gmail.com>
Y3Message-ID: <CAP4jP1fwatammPrm2nVgxmoAw=zzTLp0=0sG5XtXz4jCA+4wMQ@mail.gmail.com>
24Subject: Re: PRE-REGISTRATION EXAMINATION
� KFrom: "Patrick Rugambya/NPC" <rugambya.patrick@pharmacycouncil.rw>
IMessage-ID: <001e01d682a5$7acd54e0$7067fea0$@pharmacycouncil.rw>
2Subject: RE: PRE-REGISTRATION EXAMINATION
� ;2From: Innocent Hahirwa <innocenthahirwa@gmail.com>
Y4Message-ID: <CAP4jP1e8jFEe=ST_tF=Bh25J=CXc6MN5k=ZT+vVfTKRBcmj6Qw@mail.gmail.com>
25Subject: Re: PRE-REGISTRATION EXAMINATION
 E*From: National Pharmacy Council Rwanda <rwandanpc@gmail.com>
Y,Message-ID: <CAF5RQ=K3WUSXRrQwOunZf5EfhfGSiMcBzhTT60iqajjsJeuhgg@mail.gmail.com>
?-Subject: Pre-registration Examination Guidelines Draft
M(From: =?UTF-8?Q?UMUHIRE_KAYIBANDA_Cl=C3=A9ment?= <umukclet@yahoo.fr>
E;Message-ID: <703879066.2882857.1599467772305@mail.yahoo.com>
C>Subject: Re: Pre-registration Examination Guidelines Draft
  9.From: Albert Busumbigabo <busumbigabo@gmail.com>
Y0Message-ID: <CAMbP1p54fcittznZ9pNN=4PQA6GUY1B4T=ZD-TwyPfkqm_9RtA@mail.gmail.com>
C1Subject: Re: Pre-registration Examination Guidelines Draft
D`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200907091418.63a7cc4ecc.daa18d1f@mail59.suw13.rsgsv.net>
BSubject: =?utf-8?Q?World=20Pharmacy=20Week=20and=20more?=
 Q'From: Gasingirwa Marie-Christine <mariechristine_gasingirwa@yahoo.co.uk>
E9Message-ID: <221295427.5620826.1599506395571@mail.yahoo.com>
C<Subject: Re: Pre-registration Examination Guidelines Draft
 $,JFrom: Nilhan Uzman <Nilhan@fip.org>
eWMessage-ID:
 <AM9P193MB08878AD119FE2271E61898D6DD270@AM9P193MB0887.EURP193.PROD.OUTLOOK.COM>
fQSubject: African Pharmaceutical Forum meeting and FIP proposal for integration
 of the Forums
 T EEFrom: "CPS - Community Pharmacy Section @ FIP" <cps@fip.org>
eQMessage-ID:
 <PR3P193MB0943D6D82FAB6EC057C2CD3FB1240@PR3P193MB0943.EURP193.PROD.OUTLOOK.COM>
yISubject:
 =?Windows-1252?Q?URGENT_-_Call_for_delegates_=96_CPS_Steering_Committee_m?=
 =?Windows-1252?Q?eeting?=
�`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200916125916.21234a7110.703e8a51@mail202.atl221.rsgsv.net>
�Subject: =?utf-8?Q?Save=20the=20date=21=2021=20FIP=20Development=20Goals=20to=20transform=20global=20pharmacy=20launch=20on=20Monday?=
 `TFrom: =?utf-8?Q?International=20Pharmaceutical=20Federation?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200917125926.d65944bcd5.0626f1d8@mail202.atl221.rsgsv.net>
jSubject: =?utf-8?Q?Join=20FIP=E2=80=99s=20Digital=20Health=20in=20Pharmacy=20Education=20Survey?=
 H*DFrom: Paula Cohen <Paula@fip.org>
eMMessage-ID:
 <AM6P193MB0326E887BE17401992B5ADA5B83E0@AM6P193MB0326.EURP193.PROD.OUTLOOK.COM>
�GSubject: FIP invites you all to the official launch of the FIP Commission on
 Antimicrobial Resistance - 24 Sept 2020, 13:00 (CEST)
 x`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200921093222.5e9b06aa65.709ca20e@mail202.atl221.rsgsv.net>
wSubject: =?utf-8?Q?Let=E2=80=99s=20make=20this=2010th=20World=20Pharmacists=20Day=20the=20biggest=20so=20far?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200921131042.1a70d5b457.23ea96d5@mail59.suw13.rsgsv.net>
�Subject: =?utf-8?Q?LAUNCHED=20TODAY=21=20New=20FIP=20Development=20Goals=20unveiled=20to=20transform=20pharmacy=20together?=
 |TFrom: =?utf-8?Q?International=20Pharmaceutical=20Federation?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200922145918.26cdea3c11.38329338@mail202.atl221.rsgsv.net>
�Subject: =?utf-8?Q?Celebrate=20World=20Pharmacists=20Day=20with=20FIP=E2=80=99s=20first=2Dever=20online=20leadership=20course?=
 3GFrom: Rachel van Kesteren <Rachel@fip.org>
eOMessage-ID:
 <AM9P193MB08723C950DE7C882B3B0484CC0390@AM9P193MB0872.EURP193.PROD.OUTLOOK.COM>
;KSubject: World Pharmacists Day - 25 September 2020
 |`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200929145516.c4f6c88196.7b828955@mail59.suw13.rsgsv.net>
{Subject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28September=29?=
 X`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20200930101414.bd9af983a3.067b661e@mail59.suw13.rsgsv.net>
WSubject: =?utf-8?Q?Survey=20on=20eHealth=20and=20Digital=20Health=20Policies?=
 � K
From: "Patrick Rugambya/NPC" <rugambya.patrick@pharmacycouncil.rw>
IMessage-ID: <006001d697d4$8cf3fef0$a6dbfcd0$@pharmacycouncil.rw>
;Subject: CPD and Education Committee reinforcement
,*EFrom: Paula Cohen <Paula@fip.org>
eMMessage-ID:
 <AM6P193MB0326007AE8C6E7A6FE37438EB8300@AM6P193MB0326.EURP193.PROD.OUTLOOK.COM>
mGSubject: FW: Call for nominations Host Madsen 2021 - MOs - deadline 1 December
 2020 - kind reminder
 � //From: Darius Uzab <uzdallas@gmail.com>
Y1Message-ID: <CAKCbWjDsJ-kb5w98hs0Q3+1kpOSkAS-vFoNvtBhHMbAbXO+X7Q@mail.gmail.com>
?2Subject: Re: CPD and Education Committee reinforcement
 ;/From: Innocent Hahirwa <innocenthahirwa@gmail.com>
Y1Message-ID: <CAP4jP1c26tALRvE1dSPnVg73uxoanWKJYdrZ1DUcACb2whqaUg@mail.gmail.com>
?2Subject: Re: CPD and Education Committee reinforcement
 K
From: "Patrick Rugambya/NPC" <rugambya.patrick@pharmacycouncil.rw>
IMessage-ID: <00d201d697f3$f40e3ff0$dc2abfd0$@pharmacycouncil.rw>
?Subject: RE: CPD and Education Committee reinforcement
D`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201005065927.991e80dbbf.0f107322@mail59.suw13.rsgsv.net>
CSubject: =?utf-8?Q?FIP=20COVID=2D19=20Bulletin=20October?=
 � K
From: "Patrick Rugambya/NPC" <rugambya.patrick@pharmacycouncil.rw>
IMessage-ID: <000d01d69c02$79bf0dc0$6d3d2940$@pharmacycouncil.rw>
0Subject: Monthly report_ September 2020
�`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201007132444.77b1c77578.7aecdc5c@mail59.suw13.rsgsv.net>
�Subject: =?utf-8?Q?Save=20the=20Date=3A=20FIP=20Pharmacy=20Education=20in=20sub=2DSaharan=20Africa=20Report=20Launch=20Event=20on=20October=2020?=
 ,,DFrom: Nilhan Uzman <Nilhan@fip.org>
eNMessage-ID:
 <AM9P193MB0887CE572D50B400038EC805DD0A0@AM9P193MB0887.EURP193.PROD.OUTLOOK.COM>
pHSubject: Save the Date: FIP Pharmacy Education in sub-Saharan Africa Report
 Launch Event on October 20
 �3GFrom: Rachel van Kesteren <Rachel@fip.org>
eMMessage-ID:
 <AM9P193MB0872BC3D6B3D6147E77B880BC0080@AM9P193MB0872.EURP193.PROD.OUTLOOK.COM>
,ISubject: Draft Council minutes 2020
 h`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201012075932.b2824e563b.9f9357b7@mail202.atl221.rsgsv.net>
hSubject: =?utf-8?Q?FIP=E2=80=99s=20programme=20of=20work=20on=20non=2Dcommunicable=20diseases?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201013125919.5df3153294.73363dd3@mail59.suw13.rsgsv.net>
�Subject: =?utf-8?Q?Register=20for=20FIP=20Pharmacy=20Education=20in=20sub=2DSaharan=20Africa=20Report=20Launch=20Event=20on=20October=2020?=
 ,,DFrom: Nilhan Uzman <Nilhan@fip.org>
eNMessage-ID:
 <AM9P193MB08877A81DAE4EC0ED6F9810EDD040@AM9P193MB0887.EURP193.PROD.OUTLOOK.COM>
nHSubject: Register for FIP Pharmacy Education in sub-Saharan Africa Report
 Launch Event on October 20
 (3FFrom: Rachel van Kesteren <Rachel@fip.org>
eNMessage-ID:
 <AM9P193MB10933D108C29ECC6B6A45781C0030@AM9P193MB1093.EURP193.PROD.OUTLOOK.COM>
aHSubject: Agenda Extraordinary Council meeting on 30 November 2020 - 13.00 -
 15.00 h CET
 p`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201019083348.183a2a9f07.36969a87@mail202.atl221.rsgsv.net>
oSubject: =?utf-8?Q?FIP=20&=20COVID=2D19=20=E2=80=94=20One=20month=20on=20from=20FIP=20Virtual=202020?=
 0,CFrom: Nilhan Uzman <Nilhan@fip.org>
eMMessage-ID:
 <AM9P193MB0887B3953AFC50B29865DC21DD1E0@AM9P193MB0887.EURP193.PROD.OUTLOOK.COM>
qGSubject: Register today | FIP pharmacy education in sub-Saharan Africa Report
 Launch Event is tomorrow!
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201019125925.20ee1a40d3.b11b161b@mail202.atl221.rsgsv.net>
�Subject: =?utf-8?Q?Register=20today=20|=20FIP=20pharmacy=20education=20in=20sub=2DSaharan=20Africa=20Report=20Launch=20Event=20is=20tomorrow=21?=
 |`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201020135927.4797bcb96a.59c60dad@mail59.suw13.rsgsv.net>
ySubject: =?utf-8?Q?The=20FIP=20pharmacy=20education=20in=20sub=2DSaharan=20Africa=20report=20is=20now=20out=21?=
 ,DFrom: Nilhan Uzman <Nilhan@fip.org>
eLMessage-ID:
 <AM9P193MB08870E121B02FADDC46105C6DD1F0@AM9P193MB0887.EURP193.PROD.OUTLOOK.COM>
QHSubject: FIP pharmacy education in sub-Saharan Africa Report is now out!
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201026085930.c6e49f4cd3.e4e223cc@mail202.atl221.rsgsv.net>
~Subject: =?utf-8?Q?A=20decade=20of=20education=20partnership=20across=20Africa=3A=20FIP=E2=80=99s=20latest=20report?=
 D`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201102082926.3ea50b8485.e5ed48a9@mail202.atl221.rsgsv.net>
DSubject: =?utf-8?Q?FIP=20COVID=2D19=20Bulletin=20November?=
 ,3EFrom: Rachel van Kesteren <Rachel@fip.org>
eOMessage-ID:
 <AM8P193MB1074A891144C946742D99C04C0EF0@AM8P193MB1074.EURP193.PROD.OUTLOOK.COM>
eGSubject: FW: Agenda Extraordinary Council meeting on 30 November 2020 - 13.00
 - 15.00 h CET
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201109100036.4c31c95909.b5dcab57@mail165.atl241.mcsv.net>
�Subject: =?utf-8?Q?FIP=27s=20commitment=20to=20position=20pharmacists=20as=20one=20of=20the=20most=20effective=20primary=20health=20care=20providers?=
 �ICFrom: =?utf-8?B?R29uw6dhbG8gU291c2EgUGludG8=?= <gspinto@fip.org>
eNMessage-ID:
 <AM6P193MB0437C20626F335B20887396EA9ED0@AM6P193MB0437.EURP193.PROD.OUTLOOK.COM>
�DSubject:
 =?utf-8?B?RklQIFN1cnZleSBhbmQgV2ViaW5hciBvbiBDb21tdW5pdHkgUGhhcm1hY3ks?=
 =?utf-8?B?IFNlbGYtQ2FyZSBhbmQgT25saW5lIFBoYXJtYWN5IE9wZXJhdGlvbnMg4oCT?=
 =?utf-8?Q?_20-40_minutes?=
 3GFrom: Rachel van Kesteren <Rachel@fip.org>
eNMessage-ID:
 <AM8P193MB1074CA48D384C7047FDD2EBAC0E70@AM8P193MB1074.EURP193.PROD.OUTLOOK.COM>
TISubject: Extraordinary Council meeting 30 November 2020 - registration link
 \IDFrom: =?utf-8?B?R29uw6dhbG8gU291c2EgUGludG8=?= <gspinto@fip.org>
eKMessage-ID:
 <AM6P193MB043790255A458A8727597826A9E70@AM6P193MB0437.EURP193.PROD.OUTLOOK.COM>
}ESubject: FIP Webinar for pharmacy leaders - Community Pharmacy Regulation,
 Self-Care and Online Pharmacy Operations
 <3DFrom: Rachel van Kesteren <Rachel@fip.org>
eLMessage-ID:
 <AM8P193MB10749189DAF42AB58C076F0EC0E60@AM8P193MB1074.EURP193.PROD.OUTLOOK.COM>
uFSubject: Awards in Recognition of Excellence of Individuals 2021 - Deadline
 for nominations 1 February 2021
 h3EFrom: Rachel van Kesteren <Rachel@fip.org>
eOMessage-ID:
 <AM8P193MB10746B020C9E2BBF51ADC937C0E60@AM8P193MB1074.EURP193.PROD.OUTLOOK.COM>
�GSubject: FIP Awards in Recognition of Excellence 2021 recognising the
 activities of FIP Member Organisations - Deadline for nominations 1 February
 2021
 p`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201116093655.c577efec78.1e877e62@mail102.atl91.mcsv.net>
pSubject: =?utf-8?Q?FIP=20supports=20profession=20with=20health=20advisory=20on=20COVID=2D19=20testing?=
 p`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201119112924.4bd3131182.1763bf5b@mail102.atl91.mcsv.net>
mSubject: =?utf-8?Q?Latest=20International=20Pharmacy=20Journal=20=28November=202020=29=20out=20now?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201123085938.b7ba6a4bfb.75edefd1@mail102.atl91.mcsv.net>
~Subject: =?utf-8?Q?Your=20role=20in=20preventing=20and=20managing=20vector=2Dborne=20diseases=20and=20is=20valuable?=
 TICFrom: =?utf-8?B?R29uw6dhbG8gU291c2EgUGludG8=?= <gspinto@fip.org>
eJMessage-ID:
 <AM6P193MB0437DC2803053EFFB99B25B4A9FC0@AM6P193MB0437.EURP193.PROD.OUTLOOK.COM>
uDSubject: FIP Webinar on "Communicating vaccine safety, building vaccine
 confidence" - 27 November 13.00 CET
 |`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201125093026.547e5ea003.6d9a3ac5@mail102.atl91.mcsv.net>
zSubject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28November=29?=
 (3EFrom: Rachel van Kesteren <Rachel@fip.org>
ePMessage-ID:
 <AM8P193MB1074AA1780F3F16D6894F659C0F80@AM8P193MB1074.EURP193.PROD.OUTLOOK.COM>
cHSubject: Extraordinary Council meeting 30 November 2020 - Update and reminder
 to register
 �]$From: "International Pharmaceutical Federation" <invitations@mail.electionbuddy.com>
IMessage-ID: <11.64.02538.69221CF5@ao.mta1vrest.cc.prd.sparkpost>
�!Subject: =?utf-8?B?Vm90ZSBub3c6IEludGVybmF0aW9uYWwgUGhhcm1hY2V1dGljYWwg?=
	=?utf-8?B?RmVkZXJhdGlvbiAtIEV4dHJhb3JkaW5hcnkgQ291bmNpbCBNZWV0aW5nIA==?=
	=?utf-8?B?4oCUIFByYWN0aWNlIFZvdGU=?=
 D`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201130094030.13cbb92256.902cc9ba@mail63.sea91.rsgsv.net>
DSubject: =?utf-8?Q?FIP=20COVID=2D19=20Bulletin=20December?=
 �]$From: "International Pharmaceutical Federation" <invitations@mail.electionbuddy.com>
IMessage-ID: <3E.06.10613.4B4E4CF5@ax.mta1vrest.cc.prd.sparkpost>
�!Subject: =?utf-8?B?Vm90ZSBub3c6IEludGVybmF0aW9uYWwgUGhhcm1hY2V1dGljYWwg?=
	=?utf-8?B?RmVkZXJhdGlvbiAtIEV4dHJhb3JkaW5hcnkgQ291bmNpbCBNZWV0aW5nIA==?=
	=?utf-8?B?4oCUIFZvdGUgMS4x?=
 @(EFrom: Lina Bader <Lina@fip.org>
eMMessage-ID:
 <AM8P193MB08023144EF5A9C7DFF930170DBF50@AM8P193MB0802.EURP193.PROD.OUTLOOK.COM>
�GSubject: [Special invitation] Join us in the upcoming Transforming Vaccination
 regional events, global roundtable and Summit! 
 T`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201207085930.a1a39789a2.ade17fab@mail246.sea101.rsgsv.net>
RSubject: =?utf-8?Q?Achieving=20equity=20and=20equality=20for=20pharmacy?=
 'From: FIP <membership@fip.org>
pMessage-ID: <Nrlyc000000000000000000000000000000000000000000000QL190C00h-upUqmqT5KYJdDB8sEicw@sfdc.net>
RSubject: Invoice membership International Pharmaceutical Federation (FIP)
 8 EEFrom: "CPS - Community Pharmacy Section @ FIP" <cps@fip.org>
ePMessage-ID:
 <PR3P193MB0973EDDDF1C05186537B9091B1CB0@PR3P193MB0973.EURP193.PROD.OUTLOOK.COM>
^JSubject: Official Call for Observers to the Community Pharmacy Section FIP
 2021-2022
3EFrom: Rachel van Kesteren <Rachel@fip.org>
eLMessage-ID:
 <AM8P193MB10740BC63EFE53AC245A75B1C0CA0@AM8P193MB1074.EURP193.PROD.OUTLOOK.COM>
HHSubject: Minutes Extraordinary Council meeting 30 November 2020
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201214075928.bca0f2e1cc.ec286b76@mail182.sea71.mcsv.net>
�Subject: =?utf-8?Q?New=20guidance=20to=20design=20and=20preserve=20the=20workforce=20needed=20to=20manage=20COVID=2D19=20and=20maintain=20essential=20health=20services?=
 �ICFrom: =?utf-8?B?R29uw6dhbG8gU291c2EgUGludG8=?= <gspinto@fip.org>
eNMessage-ID:
 <AM6P193MB04375E2FA0219C5045C51DE4A9C70@AM6P193MB0437.EURP193.PROD.OUTLOOK.COM>
�DSubject:
 =?utf-8?B?W0FDVElPTiBSRVFVSVJFRF0gUmU6IEZJUCBTdXJ2ZXkgb24gQ29tbXVuaXR5?=
 =?utf-8?B?IFBoYXJtYWN5LCBTZWxmLUNhcmUgYW5kIE9ubGluZSBQaGFybWFjeSBPcGVy?=
 =?utf-8?B?YXRpb25zIOKAkyAyMC00MCBtaW51dGVz?=
 (3DFrom: Rachel van Kesteren <Rachel@fip.org>
eNMessage-ID:
 <AM8P193MB10740024218FA7E876B5C9FCC0C70@AM8P193MB1074.EURP193.PROD.OUTLOOK.COM>
dHSubject: Letter to Ministers of Health - Pharmacists' role in vaccination
 against COVID-19
 3CFrom: Rachel van Kesteren <Rachel@fip.org>
eKMessage-ID:
 <AM8P193MB10744E25CE4A01082719D5D6C0C60@AM8P193MB1074.EURP193.PROD.OUTLOOK.COM>
VFSubject: Call for nominations Bureau elections 2021- Deadline 1 February 2021
 @(EFrom: Lina Bader <Lina@fip.org>
eMMessage-ID:
 <AM8P193MB0802C82F6E60FC4E51AF40B3DBC50@AM8P193MB0802.EURP193.PROD.OUTLOOK.COM>
�GSubject: [Special invitation] Join us in the upcoming Transforming Vaccination
 regional events, global roundtable and Summit! 
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201216145201.80343fa363.90eaddbd@mail182.sea71.mcsv.net>
�Subject: =?utf-8?Q?Less=20than=2024=20hours=20to=20go=21=20Join=20the=20FIP=20Global=20Virtual=20Summit=20to=20transform=20vaccination?=
 |`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201218123307.b654e9d915.19296cd0@mail100.sea172.mcdlv.net>
zSubject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28December=29?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201221075931.ed72fd3173.cd8e1aae@mail182.sea71.mcsv.net>
�Subject: =?utf-8?Q?FIP=20Development=20Goals=20three=20months=20on=3A=20Prioritising=20transformation=20and=20implementation?=
 4`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20201221140011.71e5ae9673.f7d558c4@mail102.atl91.mcsv.net>
4Subject: =?utf-8?Q?Season=27s=20greetings?=
 �;(From: Maggie Chirwa <maggie.c@onefamilyhealth.org>
Y*Message-ID: <CAGVJbS2Fk9N6LX7SY1EBrbfDy6rwXVBAh6=K66SPjisu4BU=Mw@mail.gmail.com>
!+Subject: Farewell Rwanda
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210106084423.57218f78c5.10577fb4@mail102.atl91.mcsv.net>
�Subject: =?utf-8?Q?Pharmacy=20vaccination=20solution=20for=20COVID=2D19=20|=20FIP=2FPharmapod=20collaboration=20|=20Pre=2Dregistration=20now=20open?=
 3FFrom: Rachel van Kesteren <Rachel@fip.org>
eNMessage-ID:
 <AM8P193MB0835699C1D2CE843238B8A13C0D00@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
MJSubject: FIP Policy Statement on eHealth and Digital Health Policies
 �IDFrom: =?utf-8?B?R29uw6dhbG8gU291c2EgUGludG8=?= <gspinto@fip.org>
eOMessage-ID:
 <AM6P193MB0437A6C6A8C24953CC4847FFA9AF0@AM6P193MB0437.EURP193.PROD.OUTLOOK.COM>
�ESubject:
 =?utf-8?B?Rnc6IFtJTVBPUlRBTlQgQUNUSU9OIFJFUVVJUkVEXSBSZTogRklQIFN1cnZl?=
 =?utf-8?B?eSBvbiBDb21tdW5pdHkgUGhhcm1hY3ksIFNlbGYtQ2FyZSBhbmQgT25saW5l?=
 =?utf-8?B?IFBoYXJtYWN5IE9wZXJhdGlvbnMg4oCTIDIwLTQwIG1pbnV0ZXM=?=
 D EDFrom: "CPS - Community Pharmacy Section @ FIP" <cps@fip.org>
eOMessage-ID:
 <PR3P193MB0973769103683DF2D4F07E05B1AB0@PR3P193MB0973.EURP193.PROD.OUTLOOK.COM>
iISubject: Reminder: Official call for Observers to the Community Pharmacy
 Section FIP 2021-2022 
L`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210111082935.57315b83ef.7d12a5c4@mail180.sea22.mcdlv.net>
JSubject: =?utf-8?Q?FIP=20COVID=2D19=20Bulletin=20January=202021?=
 @3DFrom: Rachel van Kesteren <Rachel@fip.org>
eLMessage-ID:
 <AM8P193MB08350B43B999603970B24791C0AA0@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
yFSubject: FW: Awards in Recognition of Excellence of Individuals 2021 -
 Deadline for nominations 1 February 2021
 l3DFrom: Rachel van Kesteren <Rachel@fip.org>
eNMessage-ID:
 <AM8P193MB08351ACC8C2B73D054A9A366C0AA0@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
�FSubject: FW: FIP Awards in Recognition of Excellence 2021 recognising the
 activities of FIP Member Organisations - Deadline for nominations 1 February
 2021
  3CFrom: Rachel van Kesteren <Rachel@fip.org>
eKMessage-ID:
 <AM8P193MB08351497C901470F52064B0BC0AA0@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
[ESubject: FW: Call for nominations Bureau elections 2021- Deadline 1 February
 2021
 T`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210113105919.527cfb2713.bf932deb@mail135.atl101.mcdlv.net>
SSubject: =?utf-8?Q?Industrial=20Pharmacy=20Journal=20for=20FIP=20members?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210113135922.fd00b0897f.4baecb06@mail135.atl101.mcdlv.net>
�Subject: =?utf-8?Q?Save=20the=20date=3A=20FIP=20digital=20health=20in=20pharmacy=20education=20report=20launch=20on=2027=20January?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210118090325.0ca1ff63f8.6c1e5157@mail135.atl101.mcdlv.net>
�Subject: =?utf-8?Q?FIP=20continues=20to=20build=20strong=20health=20systems=20and=20healthy=20populations=20with=20the=20WHO?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210120135918.80ba0ffe89.17da0493@mail135.atl101.mcdlv.net>
�Subject: =?utf-8?Q?Register=20now=3A=20FIP=20digital=20health=20in=20pharmacy=20education=20report=20launch=20on=2027=20January?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210125085938.ad02deb297.6b876152@mail194.wdc02.mcdlv.net>
�Subject: =?utf-8?Q?Vaccination=2C=20testing=2C=20public=20messaging=2C=20and=20sharing=20findings=20in=20pharmacy=20education=3A=20FIP=E2=80=99s=20latest=20work=20to=20support=20you=20during=20the=20pandemic?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210126135927.f1389243a5.0969f98d@mail180.sea22.mcdlv.net>
�Subject: =?utf-8?Q?Don=E2=80=99t=20miss=20FIP=20digital=20health=20in=20pharmacy=20education=20report=20launch=20tomorrow?=
 |`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210127135929.05ba230616.10d9cbdf@mail135.atl101.mcdlv.net>
ySubject: =?utf-8?Q?The=20FIP=20digital=20health=20in=20pharmacy=20education=20report=20is=20now=20published=21?=
 �3DFrom: Rachel van Kesteren <Rachel@fip.org>
eJMessage-ID:
 <AM8P193MB0835080F46129D978CDD3C6CC0BB0@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
1FSubject: Request for support for Lebanon
 |`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210128133702.82caaa5fbc.49dee5d7@mail180.sea22.mcdlv.net>
ySubject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28January=29?=
 ,3DFrom: Rachel van Kesteren <Rachel@fip.org>
eOMessage-ID:
 <AM8P193MB08351F8D9D1FD8511D1344CAC0B99@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
hGSubject: FW: Call for nominations Bureau elections 2021- Deadline extended to
 28 February 2021
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210201090730.f7b0ecff3e.c8af722e@mail135.atl101.mcdlv.net>
�Subject: =?utf-8?Q?How=20FIP=E2=80=99s=20latest=20support=20for=20educators=20and=20trainers=20will=20benefit=20us=20all?=
 �3DFrom: Rachel van Kesteren <Rachel@fip.org>
eKMessage-ID:
 <AM8P193MB08351417CFA1DD54A49AFE7AC0B29@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
*GSubject: FIP Council meeting 2021
 P EEFrom: "CPS - Community Pharmacy Section @ FIP" <cps@fip.org>
ePMessage-ID:
 <PR3P193MB097369D81772CBDD8E163CA4B18D9@PR3P193MB0973.EURP193.PROD.OUTLOOK.COM>
vJSubject: For your information: Observers to the Community Pharmacy Section
 Executive Committee FIP 2021-2022
3FFrom: Rachel van Kesteren <Rachel@fip.org>
eMMessage-ID:
 <AM8P193MB0835255BCA9DE21F0433AC32C08D9@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
UHSubject: FIP Extraordinary Council meeting 24 March 2021 13.00 - 15.00 h CET
 \`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210212085922.2de305a58d.15357747@mail180.sea22.mcdlv.net>
\Subject: =?utf-8?Q?FIP=20launches=20the=20Transforming=20Vaccination=20Collection?=
 l`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210215085925.5c3ba46f7e.dced868d@mail99.suw111.mcdlv.net>
lSubject: =?utf-8?Q?Continuing=20to=20empower=20women=20in=20science=20and=20education=20in=202021?=
 <3EFrom: Rachel van Kesteren <Rachel@fip.org>
eSMessage-ID:
 <AM8P193MB083526BC7235E548DF2AC9DBC0849@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
wMSubject: Engagement meetings with Regional Pharmaceutical Forums, MOs, PSMOs,
 OOs and Bureau Liaison Officers
 3'From: Rachel van Kesteren <Rachel@fip.org>
e2Message-ID:
 <AM8P193MB08350B3CB4774C3552A7325AC0849@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
P.Subject: GoToMeeting Invitation - FIP Regional meeting - African Region
 p`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210222092432.6e28e1ad2b.c97f9f05@mail99.suw111.mcdlv.net>
nSubject: =?utf-8?Q?Transforming=20immunisation=20coverage=20during=20this=20pandemic=20and=20beyond?=
 |`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210225121529.a054c9c10e.6df06793@mail99.suw111.mcdlv.net>
zSubject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28February=29?=
 H`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210301090013.1b46eebcf0.127a3709@mail25.sea172.mcdlv.net>
HSubject: =?utf-8?Q?FIP=20COVID=2D19=20Bulletin=20March=202021?=
 ``From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210308132928.c2d1fce848.c34a7689@mail99.suw111.mcdlv.net>
`Subject: =?utf-8?Q?Continuing=20to=20support=20you=20in=20ensuring=20patient=20safety?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210309123027.4fd53c7458.9b7f7fbc@mail25.sea172.mcdlv.net>
�Subject: =?utf-8?Q?Reissued=20with=20corrected=20link=3A=20Continuing=20to=20support=20you=20in=20ensuring=20patient=20safety?=
 \`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210322085932.13193338d2.daa78511@mail99.suw111.mcdlv.net>
\Subject: =?utf-8?Q?Actions=20and=20clear=20strategies=20to=20address=20inequities?=
 x`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210329082326.ed9a1cb474.947a22b8@mail229.suw161.rsgsv.net>
uSubject: =?utf-8?Q?Recent=20FIP=20Council=20proceedings=20=E2=80=94=20A=20summary=20from=20our=20president?=
 x`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210330113008.f109fc57fa.6db60104@mail229.suw161.rsgsv.net>
wSubject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28March=29?=
 ``From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210331075928.aec7de7902.befc6ff3@mail25.sea172.mcdlv.net>
]Subject: =?utf-8?Q?Have=20you=20downloaded=20the=20Industrial=20Pharmacy=20journal?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210401115936.c60b7c560c.4a04abed@mail229.suw161.rsgsv.net>
�Subject: =?utf-8?Q?Invitation=20on=20behalf=20of=20the=20FIP=20executive=20committee=20to=20our=20member=20organisation=20leaders?=
 H`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210405075948.f18b331b98.daa5af7c@mail229.suw161.rsgsv.net>
HSubject: =?utf-8?Q?FIP=20COVID=2D19=20Bulletin=20April=202021?=
 ``From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210408075920.e343ede237.8c8e4d0b@mail229.suw161.rsgsv.net>
_Subject: =?utf-8?Q?Free=20copy=20of=20the=20latest=20Industrial=20Pharmacy=20journal?=
 P`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210412075928.990e3d4cd9.3418b0c5@mail229.suw161.rsgsv.net>
MSubject: =?utf-8?Q?Latest=20updates=20from=20the=20FIP=20president?=
 �*GFrom: Farah Aqqad <farah@fip.org>
eTMessage-ID:
 <AS8P193MB1175854A829239BC149602B9AD4F9@AS8P193MB1175.EURP193.PROD.OUTLOOK.COM>
2NSubject: Africa Regional Meeting - Agenda
 �*EFrom: Farah Aqqad <farah@fip.org>
eRMessage-ID:
 <AS8P193MB1175647A2E5AA0ECB0562E1FAD4F9@AS8P193MB1175.EURP193.PROD.OUTLOOK.COM>
3LSubject: African Regional Meeting - Agenda
 \`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210419065924.1e3c35aaa8.4dcbfb28@mail221.atl121.mcsv.net>
[Subject: =?utf-8?Q?Continued=20support=20through=20the=20pandemic=20and=20beyond?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210426075931.d9c476d891.e81d73c8@mail229.suw161.rsgsv.net>
�Subject: =?utf-8?Q?Bringing=20us=20closer=2C=20and=20bringing=20us=20back=20to=20prevention=2C=20non=2Dcommunicable=20diseases=20and=20safety?=
 x`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210427111514.be7511e966.97092866@mail229.suw161.rsgsv.net>
wSubject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28April=29?=
 p`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210429145010.2b884eb43a.650614ae@mail229.suw161.rsgsv.net>
pSubject: =?utf-8?Q?FIP=20invites=20you=20to=20co=2Dsign=20the=20African=20Medicines=20Agency=20Treaty?=
 $3DFrom: Rachel van Kesteren <Rachel@fip.org>
eNMessage-ID:
 <AM8P193MB0835F2B954C2D4869A4F1C7BC05E9@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
`HSubject: Draft FIP Statement on Digital Health - Feedback requested before 24
 May 2021
 *DFrom: Farah Aqqad <farah@fip.org>
eRMessage-ID:
 <AS8P193MB11757DEC5893441CEC5156F0AD5E9@AS8P193MB1175.EURP193.PROD.OUTLOOK.COM>
]JSubject: Meeting notes and follow up documents  - African Regional Meeting
 20210421
 *EFrom: Farah Aqqad <farah@fip.org>
eOMessage-ID:
 <AS8P193MB1175EF63204F952AA1151B03AD5E9@AS8P193MB1175.EURP193.PROD.OUTLOOK.COM>
]GSubject: Meeting notes and follow up documents  - African Regional Meeting
 20210421
 *FFrom: Dalia Bajis <dalia@fip.org>
eQMessage-ID:
 <DB9P193MB12896D826E4B8D876E13308AB05E9@DB9P193MB1289.EURP193.PROD.OUTLOOK.COM>
WJSubject: Africas: FIP Member Organisation Priorities & Provision Survey - 2021
 H`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210503075950.0e1279dea5.5483a93a@mail221.atl121.mcsv.net>
FSubject: =?utf-8?Q?FIP=20COVID=2D19=20Bulletin=20May=202021?=
  1DFrom: Nicole van Steijn <Nicole@fip.org>
eMMessage-ID:
 <DB8P193MB0583A800F3E22E20E6166F9AD3599@DB8P193MB0583.EURP193.PROD.OUTLOOK.COM>
@ISubject: Let your members know about FIP Digital Events
D`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210510075927.7d94f6e974.0c083a50@mail242.atl291.mcsv.net>
ASubject: =?utf-8?Q?Moving=20forward=20with=20One=20FIP?=
 ``From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210517075927.f42453e461.965920df@mail242.atl291.mcsv.net>
_Subject: =?utf-8?Q?COVID=2D19=3A=20Keeping=20pharmacists=20equipped=20and=20included?=
  *DFrom: Dalia Bajis <dalia@fip.org>
eLMessage-ID:
 <DB9P193MB1289E0E816452C3240A19460B02D9@DB9P193MB1289.EURP193.PROD.OUTLOOK.COM>
bFSubject: Reminder: Africas: FIP Member Organisation Priorities & Provision
 Survey - 2021
 *DFrom: Farah Aqqad <farah@fip.org>
ePMessage-ID:
 <AS8P193MB117544EAFAAE190EA61146C5AD2B9@AS8P193MB1175.EURP193.PROD.OUTLOOK.COM>
LJSubject: African Regional Meeting  / Follow up on actions 20210421 
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210524075935.f01d4a635c.8b8cdbec@mail242.atl291.mcsv.net>
�Subject: =?utf-8?Q?From=20the=20FIP=20president=3A=20How=20we=E2=80=99re=20representing=20you=20at=20the=20World=20Health=20Assembly=20this=20week?=
 x`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210528113753.cad8bbb0f7.18e29495@mail229.suw161.rsgsv.net>
uSubject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28May=29?=
 H`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210531075935.19648a2fe9.b499cedb@mail242.atl291.mcsv.net>
GSubject: =?utf-8?Q?FIP=20COVID=2D19=20Bulletin=20June=202021?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210607075926.d6d0090637.7e683a51@mail182.atl21.rsgsv.net>
�Subject: =?utf-8?Q?From=20the=20FIP=20president=3A=20Two=20new=20FIP=20publications=20available=2C=20focusing=20on=20pharmacy=20nutrition=20and=20weight=20management=20services=20and=20reporting=20on=202020?=
 83HFrom: Rachel van Kesteren <Rachel@fip.org>
ePMessage-ID:
 <AM8P193MB0835AF7CC53064B24A967EAEC0349@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
tJSubject: Invitation for virtual FIP Council meeting on 16 and 17 September
 2021 - rsvp before 12 July 2021
 X`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210614082013.7d649f3152.d66dbe14@mail229.suw161.rsgsv.net>
USubject: =?utf-8?Q?What=20can=20you=20do=20about=20vaccine=20confidence=3F?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210615125948.fddbe9d2cf.7e5cd8a8@mail229.suw161.rsgsv.net>
�Subject: =?utf-8?Q?Save=20the=20date=3A=20=E2=80=9CFIP=20UNITWIN=20Pathfinder=20Toolkit=E2=80=9D=20launch=20webinar=20on=201=20July?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210621131855.d0ab1a50a7.ad6ecee9@mail229.suw161.rsgsv.net>
�Subject: =?utf-8?Q?Welcome=20to=20our=20new=20monthly=20publication=20of=20the=20International=20Pharmacy=20Journal=21?=
 �TFrom: =?utf-8?Q?International=20Pharmaceutical=20Federation?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210622145935.aa14074958.cf7d2796@mail229.suw161.rsgsv.net>
�Subject: =?utf-8?Q?Invitation=20to=20a=20high=2Dlevel=20roundtable=20where=20health=20professions=20will=20discuss=20joining=20forces=20to=20improve=20vaccination?=
 l`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210626085920.89693cff42.96b7d6f5@mail229.suw161.rsgsv.net>
jSubject: =?utf-8?Q?Notification=20about=20the=20International=20Pharmacy=20Journal=20from=20FIP?=
 H`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210628075938.0177dfc878.5b4f8818@mail229.suw161.rsgsv.net>
GSubject: =?utf-8?Q?FIP=20COVID=2D19=20Bulletin=20July=202021?=
 x`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210629113017.f9ff99f290.c6ae9b73@mail229.suw161.rsgsv.net>
vSubject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28June=29?=
 � *'From: Farah Aqqad <farah@fip.org>
eiMessage-ID:
 <AM9P193MB18573F3842CC72B353C73078AD029@AM9P193MB1857.EURP193.PROD.OUTLOOK.COM>
7eSubject: FIP Regional Meeting - African Region
�2wFrom: prosper hiag <prosperhiag@yahoo.fr>
E�Message-ID: <1340523092.559243.1624978232694@mail.yahoo.com>
;�Subject: Re: FIP Regional Meeting - African Region
 �*GFrom: Farah Aqqad <farah@fip.org>
eUMessage-ID:
 <AM9P193MB185780AA8C92AA166C44A03FAD029@AM9P193MB1857.EURP193.PROD.OUTLOOK.COM>
9OSubject: FIP Regional Engagement Meetings - July
 P EEFrom: "CPS - Community Pharmacy Section @ FIP" <cps@fip.org>
eQMessage-ID:
 <PR3P193MB0973190B71EEDEB76C32A363B1019@PR3P193MB0973.EURP193.PROD.OUTLOOK.COM>
uISubject:
 =?Windows-1252?Q?Call_for_delegates_=96_CPS_Steering_Committee_meeting_20?=
 =?Windows-1252?Q?21?=
P EDFrom: "CPS - Community Pharmacy Section @ FIP" <cps@fip.org>
ePMessage-ID:
 <PR3P193MB0973CD1EC4398BB3B2A278FEB1019@PR3P193MB0973.EURP193.PROD.OUTLOOK.COM>
uHSubject:
 =?Windows-1252?Q?Call_for_nominations_=96_CPS_Executive_Committee_electio?=
 =?Windows-1252?Q?ns?=
X`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210701142915.156b7ae117.d36bf6da@mail229.suw161.rsgsv.net>
VSubject: =?utf-8?Q?FIP=20UNITWIN=20Pathfinder=20Toolkit=20is=20out=20now=21?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210705055947.6a1dec417d.6c465798@mail229.suw161.rsgsv.net>
�Subject: =?utf-8?Q?From=20the=20FIP=20president=3A=20Six=20things=20you=20can=20do=20to=20advance=20our=20great=20profession?=
 �*EFrom: Farah Aqqad <farah@fip.org>
eSMessage-ID:
 <AM9P193MB1857BD44D0B4F0210EF101A1AD189@AM9P193MB1857.EURP193.PROD.OUTLOOK.COM>
<MSubject: 20210721 African regional meeting - agenda
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210712065925.d872e689a9.6e3e394c@mail202.suw121.mcdlv.net>
�Subject: =?utf-8?Q?COVID=2D19=3A=20Sharing=20impacts=20on=20our=20work=20in=20long=2Dterm=20care=20facilities=20and=20universal=20health=20coverage?=
 ``From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210714142913.982f54f687.7deec5eb@mail202.suw121.mcdlv.net>
_Subject: =?utf-8?Q?Free=20copy=20of=20the=20latest=20Industrial=20Pharmacy=20Journal?=
 �*EFrom: Farah Aqqad <farah@fip.org>
eRMessage-ID:
 <AM9P193MB18576DE6EFCDD223DE5481B3AD119@AM9P193MB1857.EURP193.PROD.OUTLOOK.COM>
@LSubject: FW: 20210721 African regional meeting - agenda
 ( EEFrom: "CPS - Community Pharmacy Section @ FIP" <cps@fip.org>
eMMessage-ID:
 <PR3P193MB0973B1C5644928E33F08D494B1E19@PR3P193MB0973.EURP193.PROD.OUTLOOK.COM>
MISubject: Resending Calls - Call for Delegates and Call for Elections
�`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210719081440.ac364d89b1.79325c80@mail202.suw121.mcdlv.net>
�Subject: =?utf-8?Q?H=C3=B8st=2DMadsen=20Medallist=20talks=20gene=20&=20nucleic=20acid=20therapies=20in=20the=20latest=20International=20Pharmacy=20Journal?=
  EEFrom: "CPS - Community Pharmacy Section @ FIP" <cps@fip.org>
eMMessage-ID:
 <PR3P193MB09739E4FF84BAB45AA71EC33B1E19@PR3P193MB0973.EURP193.PROD.OUTLOOK.COM>
8ISubject: National Pharmacy Champions for Change
H`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210726075944.edb22bd770.c632dba6@mail229.suw161.rsgsv.net>
GSubject: =?utf-8?Q?FIP=20COVID=2D19=20Bulletin=20July=202021?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210728104627.3f04caa0b0.33d7d8e3@mail229.suw161.rsgsv.net>
�Subject: =?utf-8?Q?Invitation=20as=20Special=20Guest=20=E2=80=93=20APF=20Regional=20Workshop=202021=20=E2=80=93=20Virtual=20Participation?=
 x`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210729090009.3d24f9c8e8.e072e098@mail202.suw121.mcdlv.net>
vSubject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28July=29?=
 p`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210802075927.f81f2fcba7.c9183e2e@mail225.atl81.rsgsv.net>
pSubject: =?utf-8?Q?New=20FIP=20report=20provides=20intelligence=20to=20advance=20community=20pharmacy?=
 *EFrom: Farah Aqqad <farah@fip.org>
eRMessage-ID:
 <AM9P193MB1857AE4DDD8B2E1F35286940ADEF9@AM9P193MB1857.EURP193.PROD.OUTLOOK.COM>
NLSubject: RE: 20210721 African regional meeting - follow up documents 
 |`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210805115924.daa647cc75.0a7aba7c@mail202.suw121.mcdlv.net>
{Subject: =?utf-8?Q?Special=20invitation=20from=20FIP=20to=20join=20FIP=2DUNESCO=20UNITWIN=20Regional=20Workshops?=
 p`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210809075923.6e58fed503.bd3d2b29@mail221.suw14.mcdlv.net>
mSubject: =?utf-8?Q?From=20the=20FIP=20President=3A=20Inequity=20in=20health=20threatens=20us=20all?=
 'From: Ozge Ozer <ozge@fip.org>
pMessage-ID: <soCsG000000000000000000000000000000000000000000000QXOBVS00q-hzzpiRQjC7fjE34ev1qw@sfdc.net>
RSubject: Invitation: Help us build the FIP World List of Pharmacy Schools
 X`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210816103623.4414c260b3.e1a76b16@mail232.suw161.rsgsv.net>
VSubject: =?utf-8?Q?International=20Pharmacy=20Journal=20=2D=20August=202021?=
 ``From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210817082912.98e93558ca.7a0f14cb@mail232.suw161.rsgsv.net>
_Subject: =?utf-8?Q?Free=20copy=20of=20the=20latest=20Industrial=20Pharmacy=20Journal?=
 L`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210823093556.92ba1b3a3d.9cca172f@mail232.suw161.rsgsv.net>
ISubject: =?utf-8?Q?FIP=20COVID=2D19=20Bulletin=20August=202021?=
 T EDFrom: "CPS - Community Pharmacy Section @ FIP" <cps@fip.org>
eQMessage-ID:
 <PR3P193MB0973D30E89F5411E858C4525B1C59@PR3P193MB0973.EURP193.PROD.OUTLOOK.COM>
yISubject:
 =?Windows-1252?Q?2nd_Call_for_delegates_=96_CPS_Steering_Committee_meetin?=
 =?Windows-1252?Q?g_2021?=
x`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210826103655.3a56cf1d42.e3307177@mail232.suw161.rsgsv.net>
xSubject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28August=29?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210827085454.f2ad9d90d3.beedd999@mail221.suw14.mcdlv.net>
�Subject: =?utf-8?Q?Reminder=3A=20Special=20invitation=20from=20FIP=20to=20join=20FIP=2DUNESCO=20UNITWIN=20Regional=20Workshops?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210830105736.1ff196877c.c1c52577@mail231.sea81.mcsv.net>
�Subject: =?utf-8?Q?From=20the=20FIP=20president=3A=20Hundreds=20of=20colleagues=20from=20151=20UN=20countries=20have=20joined=20our=20campaign=2C=20now=20I=20call=20on=20you=21?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210906084050.1496e99cc2.78df2312@mail222.atl291.mcsv.net>
�Subject: =?utf-8?Q?From=20the=20FIP=20President=3A=20We=20must=20be=20prepared=20for=20growing=20demands=20for=20mental=20health=20care?=
 T EBFrom: "CPS - Community Pharmacy Section @ FIP" <cps@fip.org>
eOMessage-ID:
 <DBAP193MB097148D6A4D503DF0AAA858AB1D49@DBAP193MB0971.EURP193.PROD.OUTLOOK.COM>
yGSubject:
 =?Windows-1252?Q?URGENT_-_Call_for_delegates_=96_CPS_Steering_Committee_M?=
 =?Windows-1252?Q?eeting?=
PTFrom: =?utf-8?Q?International=20Pharmaceutical=20Federation?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210913092449.16736cad35.d31ee724@mail185.atl241.mcsv.net>
YSubject: =?utf-8?Q?International=20Pharmacy=20Journal=20=2D=20September=202021?=
 $6DFrom: Alison Ubong Etukakpan <Alison@fip.org>
eQMessage-ID:
 <AM9P193MB174741D62DEFCD46B56D059DC7D99@AM9P193MB1747.EURP193.PROD.OUTLOOK.COM>
[KSubject: Message from FIP and APF Presidents- Join FIP UNITWIN Regional
 Workshops
 L`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210920081428.eeab5f2dff.6f9013f1@mail105.sea21.rsgsv.net>
LSubject: =?utf-8?Q?FIP=20COVID=2D19=20Bulletin=20September=202021?=
 |`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210928092829.1404b38b50.a6f56f07@mail185.atl241.mcsv.net>
zSubject: =?utf-8?Q?What=20happened=20at=20the=20FIP=20Council=20Meeting=3F=20The=20FIP=20president=20summarises?=
 �*CFrom: Farah Aqqad <farah@fip.org>
ePMessage-ID:
 <PR3P193MB1006E00E255A37E7074902ABADA89@PR3P193MB1006.EURP193.PROD.OUTLOOK.COM>
6JSubject: [Invitation]: FIP interview with NPC
 HTFrom: =?utf-8?Q?International=20Pharmaceutical=20Federation?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210929065936.186dc6a2d6.ea434654@mail163.sea101.rsgsv.net>
QSubject: =?utf-8?Q?FIP=20Foundation=20welcomes=20new=20board=20members?=
 EBFrom: "CPS - Community Pharmacy Section @ FIP" <cps@fip.org>
eKMessage-ID:
 <PR3P193MB0973557A094807F3D40DC7A0B1A99@PR3P193MB0973.EURP193.PROD.OUTLOOK.COM>
8GSubject: News from the CPS - Call for observers
 |`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210929103008.c1c884416e.7e3dd5a5@mail163.sea101.rsgsv.net>
{Subject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28September=29?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20210929125944.6c0d2f8283.bbf19c1e@mail163.sea101.rsgsv.net>
�Subject: =?utf-8?Q?Save=20the=20date=3A=20=E2=80=98=E2=80=99FIPWiSE=20toolkit=20for=20positive=20practice=20environments=20for=20women=20in=20science=20and=20education=E2=80=99=E2=80=99=20launch=20on=20October=2012?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211004072924.fb140e03b5.ab0025d6@mail85.atl301.rsgsv.net>
�Subject: =?utf-8?Q?From=20the=20FIP=20President=3A=20We=20must=20take=20a=20strong=20role=20this=20influenza=20season?=
 �*&From: Farah Aqqad <farah@fip.org>
e/Message-ID:
 <PR3P193MB1006B421D8D43A3EA9407178ADAE9@PR3P193MB1006.EURP193.PROD.OUTLOOK.COM>
7+Subject: FIP Regional Meeting - African Region
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
tMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211006134425.d7e88087bd.5914ce09@mail97.sea31.mcsv.net>
�Subject: =?utf-8?Q?Last=20call=20to=20register=20for=20FIP=2DUNESCO=20UNITWIN=20Regional=20Workshops=2D=2D=20Please=20RSVP=20by=20October=2011?=
 P`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211011082930.68df948c5f.b19a9fbb@mail185.atl241.mcsv.net>
PSubject: =?utf-8?Q?International=20Pharmacy=20Journal=20=28October=29?=
 �*BFrom: Farah Aqqad <farah@fip.org>
eLMessage-ID:
 <AS8P193MB236623EAF597B9BF00646E0AADB59@AS8P193MB2366.EURP193.PROD.OUTLOOK.COM>
:HSubject: RE: [Invitation]: FIP interview with NPC
 h`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211012142933.02ac6fc63b.376fb03b@mail49.atl301.rsgsv.net>
hSubject: =?utf-8?Q?FIPWiSE=20positive=20practice=20environments=20toolkit=20is=20out=20now=21?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211014130002.003225cf3d.4fe483ad@mail163.sea101.rsgsv.net>
}Subject: =?utf-8?Q?Save=20the=20date=3A=20FIP=20Global=20Summit=20on=20Primary=20Health=20Care=20on=2025=20October?=
 L`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211017075940.86d876fe5c.fcaa9e19@mail49.atl301.rsgsv.net>
JSubject: =?utf-8?Q?FIP=20COVID=2D19=20Bulletin=20October=202021?=
 �,EFrom: Roua Alrashdan <Roua@fip.org>
ePMessage-ID:
 <AM9P193MB1476A3AE20E7AB84249F5DDDD8BD9@AM9P193MB1476.EURP193.PROD.OUTLOOK.COM>
@KSubject: [Invitation] FIP Pandemic preparedness project
 ,FFrom: Roua Alrashdan <Roua@fip.org>
ePMessage-ID:
 <AM9P193MB1476BDF39E9CE858CDBFBFF7D8BE9@AM9P193MB1476.EURP193.PROD.OUTLOOK.COM>
DLSubject: RE: [Invitation] FIP Pandemic preparedness project
 �*FFrom: Farah Aqqad <farah@fip.org>
eRMessage-ID:
 <AS8P193MB2366EE35D5522094C2CC766FADBE9@AS8P193MB2366.EURP193.PROD.OUTLOOK.COM>
7LSubject: FIP Regional Meeting - African Region
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211025055935.64564413e7.0cb4717c@mail83.sea172.mcdlv.net>
}Subject: =?utf-8?Q?Cementing=20our=20place=20in=20primary=20health=20care=20=E2=80=94=20New=20support=20from=20FIP?=
 �*DFrom: Farah Aqqad <farah@fip.org>
eTMessage-ID:
 <AS8P193MB2366361071D7C15EE9B13AF2AD839@AS8P193MB2366.EURP193.PROD.OUTLOOK.COM>
@NSubject: [Agenda] FIP Regional Meeting - African Region
 |`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211028104631.a32b938b52.f31d5f7d@mail167.atl81.rsgsv.net>
ySubject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28October=29?=
 T`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211031105939.961f20dbf2.c6c207a7@mail254.atl21.rsgsv.net>
QSubject: =?utf-8?Q?FIP=20actions=20on=20climate=20change=20and=20COP26?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211101085949.3f5ec9fa48.10c8b733@mail162.suw101.mcdlv.net>
�Subject: =?utf-8?Q?From=20the=20FIP=20President=3A=20Protecting=20healthcare=20workers=2C=20protecting=20our=20pharmaceutical=20science=20and=20education=20workforce=2C=20during=20COVID=20and=20beyond?=
 LTFrom: =?utf-8?Q?International=20Pharmaceutical=20Federation?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211108091448.f944cfeab8.4bc0cfd5@mail254.atl21.rsgsv.net>
XSubject: =?utf-8?Q?International=20Pharmacy=20Journal=20=2D=20November=202021?=
 p`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211109081416.0109aac5cc.cda26776@mail75.wdc01.mcdlv.net>
mSubject: =?utf-8?Q?Survey=3A=C2=A0Pediatric=20Oral=20Extemporaneous=20Preparations=20&=20Practices?=
 PEFFrom: "CPS - Community Pharmacy Section @ FIP" <cps@fip.org>
eQMessage-ID:
 <PR3P193MB09737D77A28729DEF5358700B1929@PR3P193MB0973.EURP193.PROD.OUTLOOK.COM>
vKSubject: For your information: Observers to the Community Pharmacy Section
 Executive Committee FIP 2021-2022
 *DFrom: Farah Aqqad <farah@fip.org>
eTMessage-ID:
 <AS8P193MB2366A5CB620EAC426B117C57AD959@AS8P193MB2366.EURP193.PROD.OUTLOOK.COM>
FNSubject: [Padlet link]: FIP Regional Meeting - African Region
 L`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211115075943.a1d3ce2b67.1d4c92ef@mail162.suw101.mcdlv.net>
KSubject: =?utf-8?Q?FIP=20COVID=2D19=20Bulletin=20November=202021?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211115144308.1d49059b0e.65887c92@mail162.suw101.mcdlv.net>
�Subject: =?utf-8?Q?Registration=20is=20now=20open=20for=20the=20FIP=2DUNITWIN=20Global=20Summit=20on=20Pharmaceutical=20Education?=
 `TFrom: =?utf-8?Q?International=20Pharmaceutical=20Federation?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211116125936.ffb7a0a373.52d376f3@mail75.wdc01.mcdlv.net>
kSubject: =?utf-8?Q?FIP=20Transforming=20Vaccination=20Summit=20=E2=80=93=202=20days=20to=20go=21?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211123110140.2dbe59219e.a57bb0e8@mail162.suw101.mcdlv.net>
�Subject: =?utf-8?Q?Diabetes=2C=20vaccination=20and=20AMR=3A=20We=20support=20you=20in=20all=20three=20areas=20with=20more=20resources=20this=20month?=
 3DFrom: Rachel van Kesteren <Rachel@fip.org>
eLMessage-ID:
 <AM8P193MB0835389484C6911DBF41C008C0609@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
WGSubject: Call for nominations - Bureau Elections 2022 deadline 1 February 2022
 4From:  Acrobat Reader<support@chuksmtp.xyz>
CMessage-ID: <20211123172150.13D64E3740721ED4@chuksmtp.xyz>
oSubject: @innocent.hahirwa,a document (MT103-FE4DGR788//Remittance Copy.pdf) has been shared with you!
 |`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211125123019.5efdb15131.4bcfd9ee@mail96.sea21.rsgsv.net>
zSubject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28November=29?=
 \`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211130085200.3878d27d38.f7c507b0@mail194.atl221.rsgsv.net>
\Subject: =?utf-8?Q?Preparedness=20for=20future=20pandemics=20and=20new=20variants?=
 �'From: FIP <membership@fip.org>
pMessage-ID: <HHvhD000000000000000000000000000000000000000000000R3JPI700KZcJKYf_RX26qt2zVzbGWQ@sfdc.net>
-Subject: FIP membership invoice 2022
 *DFrom: Farah Aqqad <farah@fip.org>
eUMessage-ID:
 <AS8P193MB2366DA8D67E8A3966DA2EB04AD6D9@AS8P193MB2366.EURP193.PROD.OUTLOOK.COM>
DNSubject: [Follow-up]: FIP Regional Meeting - African Region
 X`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211206082950.f71f2964c9.e34be745@mail227.suw241.rsgsv.net>
XSubject: =?utf-8?Q?International=20Pharmacy=20Journal=20=28December=202021=29?=
 (3FFrom: Rachel van Kesteren <Rachel@fip.org>
eNMessage-ID:
 <AM8P193MB0835168F9E16089FD6FBBA20C06F9@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
bHSubject: Call for nominations for FIP Statements in 2022/2023 - Deadline 17
 January 2022
 L`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211213082935.50b4eb7115.a8f82ad5@mail194.atl221.rsgsv.net>
KSubject: =?utf-8?Q?FIP=20COVID=2D19=20Bulletin=20December=202021?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211213132942.274cff8914.3a5556bc@mail162.suw101.mcdlv.net>
�Subject: =?utf-8?Q?Pledge=20your=20commitment=20to=20FIP=E2=80=99s=20global=20call=20to=20action=20for=20advancing=20pharmaceutical=20education?=
 |`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211216105003.9ea4802060.1bb998e8@mail162.suw101.mcdlv.net>
zSubject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28December=29?=
 4`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211220101447.1aad94a596.6ad4dcae@mail162.suw101.mcdlv.net>
4Subject: =?utf-8?Q?Season=27s=20greetings?=
 D*DFrom: Paula Cohen <Paula@fip.org>
eLMessage-ID:
 <AM0P193MB04204E78FEF0A60E84EA4BC9B87C9@AM0P193MB0420.EURP193.PROD.OUTLOOK.COM>
�FSubject: FIP MOs - call for Seville 2022 "Pharmacy United in the Recovery of
 Healthcare" (1) - please submit by 1 March 2022
 x`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20211230111433.d04582451d.67ad9014@mail162.suw101.mcdlv.net>
wSubject: =?utf-8?Q?Today=20is=20700=20days=20since=20COVID=2D19=20was=20officially=20declared=20a=20pandemic?=
 t`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220104153722.3e5f36347c.3d32985f@mail194.atl221.rsgsv.net>
sSubject: =?utf-8?Q?Put=20a=20spotlight=20on=20your=20organisation=E2=80=99s=20work=20during=20COVID=2D19?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220110075948.da5ca8780d.caf1c7d6@mail65.suw231.rsgsv.net>
~Subject: =?utf-8?Q?From=20the=20FIP=20President=3A=20Which=20FIP=20programmes=20will=20you=20support=20in=202022=3F?=
 43DFrom: Rachel van Kesteren <Rachel@fip.org>
eLMessage-ID:
 <AM8P193MB08350A1B15B7186FF7881149C0549@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
oFSubject: Awards in Recognition of Excellence 2022 - MOs & PSMOs Deadline for
 nominations 1 March 2022
 43DFrom: Rachel van Kesteren <Rachel@fip.org>
eLMessage-ID:
 <AM8P193MB0835C2387E181AF962D07EDBC0549@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
oFSubject: Awards in Recognition of Excellence 2022 - Individuals Deadline for
 nominations 1 March 2022
 ,3DFrom: Rachel van Kesteren <Rachel@fip.org>
eLMessage-ID:
 <AM8P193MB0835CF79A4F6015B496C9508C0549@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
fFSubject: FW: Call for nominations for FIP Statements in 2022/2023 - Deadline
 17 January 2022
 ``From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220117075951.0302c2ca22.26f3c87d@mail55.suw111.mcdlv.net>
_Subject: =?utf-8?Q?Stay=20strong=20and=20united=20as=20we=20enter=20COVID=20year=203?=
 L0DFrom: Sherly Meilianti <sherly@fip.org>
eTMessage-ID:
 <AS8P193MB12230744B3AB1C5AA604F2A1C8589@AS8P193MB1223.EURP193.PROD.OUTLOOK.COM>
�KSubject:
 =?utf-8?B?W1JlbWluZGVyXSBGSVAgUGFuZGVtaWMgcHJlcGFyZWRuZXNzIHByb2plY3Qg?=
 =?utf-8?B?4oCTIGJ5IDI4IEZlYnJ1YXJ5IDIwMjI=?=
 X`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
vMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220124092230.8a156275c4.e706f017@mail65.suw231.rsgsv.net>
WSubject: =?utf-8?Q?International=20Pharmacy=20Journal=20=28January=202022=29?=
 |`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220127152547.cf65326b7a.a3ba9081@mail29.atl18.mcdlv.net>
ySubject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28January=29?=
 L`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220131075935.1a8d3dddc1.04236b60@mail194.atl221.rsgsv.net>
JSubject: =?utf-8?Q?FIP=20COVID=2D19=20Bulletin=20January=202022?=
  3EFrom: Rachel van Kesteren <Rachel@fip.org>
eOMessage-ID:
 <AM8P193MB0835C003DA50618DBF1383A7C0259@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
\GSubject: FW: Call for nominations - Bureau Elections 2022 deadline 1 February
 2022
 �`!From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
u%Message-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220214082932.3259d052bc.b5246ba3@mail29.atl18.mcdlv.net>
~ Subject: =?utf-8?Q?Help=20FIP=20find=20=22rising=20stars=E2=80=9D=20in=20pharmaceutical=20science=20and=20education?=
 06EFrom: Alison Ubong Etukakpan <Alison@fip.org>
eQMessage-ID:
 <AS8P193MB15128C4F326F7809C636D298C7359@AS8P193MB1512.EURP193.PROD.OUTLOOK.COM>
fISubject: [Reminder] How did you respond to the COVID-19 pandemic? Let us know
 by 28 Feb     
 X`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220221075934.1a9f97a261.ceafc348@mail194.atl221.rsgsv.net>
XSubject: =?utf-8?Q?International=20Pharmacy=20Journal=20=28February=202022=29?=
 |`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220224115959.42bbd1ba8a.bb042147@mail29.atl18.mcdlv.net>
zSubject: =?utf-8?Q?Get=20The=20Global=20Picture=3A=20FIP=20Member=20Organisations=20Newsletter=20=28February=29?=
 83BFrom: Rachel van Kesteren <Rachel@fip.org>
eJMessage-ID:
 <AM8P193MB08357B44F3B78B72BFB4341EC03E9@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
sDSubject: FW: Awards in Recognition of Excellence 2022 - MOs & PSMOs Deadline
 for nominations 1 March 2022
 3GFrom: Rachel van Kesteren <Rachel@fip.org>
eOMessage-ID:
 <AM8P193MB08359F86D2A989D84570B9DBC03E9@AM8P193MB0835.EURP193.PROD.OUTLOOK.COM>
EISubject: Extraordinary Council meeting 7 April 2022 - Agenda
 l`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220228065927.df39cb3e0f.7b102cab@mail194.atl221.rsgsv.net>
lSubject: =?utf-8?Q?=22Our=20government=20declared=20pharmacy=20services=20as=20essential=E2=80=9D?=
 x`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220307075932.86a8a64897.d889a42f@mail100.atl301.rsgsv.net>
wSubject: =?utf-8?Q?=E2=80=9CWe=20have=20a=20duty=20to=20provide=20aid=E2=80=9D=20=E2=80=94=20FIP=20President?=
 P`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220310095930.e29f38b25a.cbb7d9d3@mail29.atl18.mcdlv.net>
OSubject: =?utf-8?Q?FIP=20engagement=20with=20our=20membership=202021?=
 XTFrom: =?utf-8?Q?International=20Pharmaceutical=20Federation?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220312085915.4cece42970.cff106bc@mail204.sea81.mcsv.net>
aSubject: =?utf-8?Q?Call=20for=20FIP=20Foundation=20Board=20of=20Director=20nominations?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
rMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220314085927.25965f7a66.a9966aac@mail12.us4.mcsv.net>
�Subject: =?utf-8?Q?Equipping=20the=20profession=20to=20tackle=20one=20of=20the=20decade=E2=80=99s=20urgent=20health=20challenges?=
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
uMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220315085933.cb6e6972db.58673967@mail204.sea81.mcsv.net>
�Subject: =?utf-8?Q?Have=20you=20suggested=20a=20FIPWiSE=20rising=20star=3F=20Deadline=20extended=20to=2015=20April=20with=20updated=20criteria?=
 �CFrom: Webmail Admin Support <siy.wai@melbournelibrary.com>
K!Message-ID: <20220316053353.422DA5D67AD176D5@melbournelibrary.com>
5Subject: ATTN: Notice of Unusual Activity!!!
 X`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220321084027.789fa10b4b.3a8fcc5f@mail194.atl221.rsgsv.net>
USubject: =?utf-8?Q?International=20Pharmacy=20Journal=20=28March=202022=29?=
 �?From: pharmacycouncil.rw<siy.wai@melbournelibrary.com>
K!Message-ID: <20220321082631.E5871E74E87838C9@melbournelibrary.com>
5Subject: Unusual Activity Has Been Detected!
 �-EFrom: Branka Brglez <Branka@fip.org>
eOMessage-ID:
 <VI1P193MB0574711496C8E3972056313CC4179@VI1P193MB0574.EURP193.PROD.OUTLOOK.COM>
 KSubject: FIP membership
 �EFrom: innocent.hahirwa WebmailService <biosud@biosud.com.ar>
DMessage-ID: <20220327150127.B65F6DDD43442345@biosud.com.ar>
2Subject: Unexpected activity was noticed!
 p`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
wMessage-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220328072922.4408be67cc.353b5b84@mail194.atl221.rsgsv.net>
oSubject: =?utf-8?Q?=22Pharmacy=27s=20pandemic=20changes=20include=20greater=20collaboration=E2=80=9D?=
 x`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
w Message-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220404072935.d1f6be4a77.ec3fa29a@mail194.atl221.rsgsv.net>
xSubject: =?utf-8?Q?FIP=20collaborates=20with=20energy=20suppliers=20on=20improving=20healthcare=20in=20Africa?=
 @`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
v Message-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220411072944.0caa83943b.064ca9e8@mail238.atl241.mcsv.net>
?Subject: =?utf-8?Q?FIP=20COVID=2D19=20Update=20April?=
 (IDFrom: =?Windows-1252?Q?Gon=E7alo_Sousa_Pinto?= <gspinto@fip.org>
eIMessage-ID:
 <DB9P193MB15148368AE7E9A6162CD4B6DA9C29@DB9P193MB1514.EURP193.PROD.OUTLOOK.COM>
IESubject: Webinar for pharmacy regulators on mandatory CPD models
 �`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
v Message-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220509075941.fcfa94edc7.8eb86cb7@mail120.suw91.mcdlv.net>
�Subject: =?utf-8?Q?Pharmacy=E2=80=99s=20strong=20response=20supported=20health=20care=2C=20aided=20economic=20recovery=20and=20helped=20children=20back=20to=20school?=
 @`From: =?utf-8?Q?International=20Pharmaceutical=20Federation=20=28FIP=29?= <fip@fip.org>
u Message-ID: <8a53014ef869b0c219eac7e5f.6d799f3a46.20220606075937.82939d5795.b9c9c6b7@mail68.sea21.rsgsv.net>
>Subject: =?utf-8?Q?FIP=20COVID=2D19=20Update=20June?=
 XIDFrom: =?Windows-1252?Q?Gon=E7alo_Sousa_Pinto?= <gspinto@fip.org>
eKMessage-ID:
 <DB9P193MB151450BC7D9F7E746F82AE84A9BD9@DB9P193MB1514.EURP193.PROD.OUTLOOK.COM>
zESubject: Falsified medicines and misinformation on the internet: Public risk
 and solutions - FIP WEBINAR 12 JULY
 *DFrom: Paula Cohen <Paula@fip.org>
eLMessage-ID:
 <AM0P193MB0420C1967A3C413AB7DADB11B8209@AM0P193MB0420.EURP193.PROD.OUTLOOK.COM>
_FSubject: FIP Regulators Forum - meeting & symposium - Save the dates 22 & 23
 Nov 2022
[D].Drafts
[D].Junk
[D].Sent
[D].spam
[D].Trash
[D]cur
[D]new
[D]tmp
[F]dovecot-quota
[F]dovecot-uidlist
[F]dovecot-uidvalidity
[F]dovecot-uidvalidity.5ec39a8e
[F]dovecot.index
[F]dovecot.index.cache
[F]dovecot.index.log
[F]dovecot.list.index.log
[F]dovecot.mailbox.log
[F]maildirsize
[F]subscriptions